Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian D Sanders

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Critical Care Medicine|June 22, 2007
An economic evaluation of prolonged mechanical ventilationChristopher E Cox, Shannon S Carson, Joseph A Govert, et al.
American Heart Journal|September 14, 2002
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillatorDouglas K Owens, Gillian D Sanders, Paul A Heidenreich, et al.
Cancer|November 7, 2003
Decision science and cervical cancerScott B Cantor, Marianne C Fahs, Jeanne S Mandelblatt, et al.
American Heart Journal|May 22, 2012
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritizationMatthew J Crowley, Benjamin J Powers, Evan R Myers, et al.
Cardiology Journal|September 28, 2011
Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysisMelissa H Kong, Sana M Al-Khatib, Gillian D Sanders, et al.
Annals of Internal Medicine|August 1, 2012
Identifying research needs for improving health careStephanie M Chang, Timothy S Carey, Elisabeth Uphoff Kato, et al.
BMC Pediatrics|March 17, 2012
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritisAlex R Kemper, Heather A Van Mater, Remy R Coeytaux, et al.
Arthritis Care & Research|October 19, 2011
Psychometric characteristics of outcome measures in juvenile idiopathic arthritis: a systematic reviewHeather A van Mater, John W Williams, Remy R Coeytaux, et al.
Journal of Critical Care|November 5, 2003
Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsisRobert A Fowler, Marya Hill-Popper, John Stasinos, et al.
American Heart Journal|November 2, 2013
Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillationNancy M Allen LaPointe, Yuliya Lokhnygina, Gillian D Sanders, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Critical Care Medicine|June 22, 2007
An economic evaluation of prolonged mechanical ventilationChristopher E Cox, Shannon S Carson, Joseph A Govert, et al.
American Heart Journal|September 14, 2002
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillatorDouglas K Owens, Gillian D Sanders, Paul A Heidenreich, et al.
Cancer|November 7, 2003
Decision science and cervical cancerScott B Cantor, Marianne C Fahs, Jeanne S Mandelblatt, et al.
American Heart Journal|May 22, 2012
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritizationMatthew J Crowley, Benjamin J Powers, Evan R Myers, et al.
Cardiology Journal|September 28, 2011
Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysisMelissa H Kong, Sana M Al-Khatib, Gillian D Sanders, et al.
Annals of Internal Medicine|August 1, 2012
Identifying research needs for improving health careStephanie M Chang, Timothy S Carey, Elisabeth Uphoff Kato, et al.
BMC Pediatrics|March 17, 2012
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritisAlex R Kemper, Heather A Van Mater, Remy R Coeytaux, et al.
Arthritis Care & Research|October 19, 2011
Psychometric characteristics of outcome measures in juvenile idiopathic arthritis: a systematic reviewHeather A van Mater, John W Williams, Remy R Coeytaux, et al.
Journal of Critical Care|November 5, 2003
Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsisRobert A Fowler, Marya Hill-Popper, John Stasinos, et al.
American Heart Journal|November 2, 2013
Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillationNancy M Allen LaPointe, Yuliya Lokhnygina, Gillian D Sanders, et al.
Pageof 15